PARP/HDAC-IN-1 is a selective PARP and HDAC inhibitor with potential anticancer activity, inhibits PARP1, PARP2 and HDAC1, and may be used in the study of pancreatic cancer.
Molecular Weight:
634.67
Purity:
95.00%
Formula:
C36H32F2N6O3
Target:
PARP|||HDAC
T85321
* VAT and and shipping costs not included. Errors and price changes excepted